Thursday, July 9, 2026

pharma · INDP

Indaptus Therapeutics

Indaptus Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

NEW YORK, NY, USA HQ
Public company Type
INDP · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, USA
Programs
0
Drugs
0
Patents
1
Intelligence · Drug Pipeline

Indaptus Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Indaptus Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →